HHS Cancels $766 Million Moderna Funding For Investigational Influenza Vaccines  

The U.S. Department of Health & Human Services (HHS) terminated its Biden-administration-era $766 million funding to Moderna for investigational influenza vaccines. The funds were awarded through the Biomedical Advanced Research and Development Authority (BARDA), a program that focuses on rapid development of medical treatments for public health emergencies.;

The funding was initially pledged to help the company develop, test, and license messenger ribonucleic acid (mRNA)-based vaccines to combat pandemic flu viruses, including bird flu in humans. mRNA is a single stranded molecule that carries the instructions to make proteins. It has a fundamental and essential . . .